1. Home
  2. Analysis

Bleeding disorders and drugs of ingredients of poison ivy - a phase IV clinical study of FDA data


Summary:

Bleeding disorders is reported only by a few people who take drugs with ingredients of poison ivy. This phase IV clinical study analyzes 52 people who have side effects while taking drugs with ingredients of poison ivy from the the FDA. Among them, 4 have Bleeding disorders. Find out below who they are, when they have Bleeding disorders and more.

Drug(s) considered in the study (i.e. both brand name and generic drugs): Markweed, Poison ivy, Poison vine, Rhus radicans, Rhus tox, Rhus toxicodendron, Three-leafed ivy, Toxicodendron pubescens, Toxicodendron quercifolium, Toxicodendron radicans, Toxicodendron toxicarium.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On May, 30, 2023

52 people reported to have side effects when taking drugs with ingredients of poison ivy.
Among them, 4 people (7.69%) have Bleeding disorders

What is Bleeding disorders?

Bleeding disorders is found to be associated with 2,223 drugs and 1,575 conditions by eHealthMe.

Number of reports submitted per year:

Could drugs with ingredients of poison ivy cause Bleeding disorders?

Time on drugs with ingredients of poison ivy when people have Bleeding disorders *:

  • < 1 month: 100 %
  • 1 - 6 months: 0.0 %
  • 6 - 12 months: 0.0 %
  • 1 - 2 years: 0.0 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

Gender of people who have Bleeding disorders when taking drugs with ingredients of poison ivy *:

  • female: 100 %
  • male: 0.0 %

Age of people who have Bleeding disorders when taking drugs with ingredients of poison ivy *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 0.0 %
  • 50-59: 50 %
  • 60+: 50 %

Conditions people have *:

  1. Type 2 Diabetes: 2 people, 50.00%
  2. Seasonal Allergy (allergic condition due to certain season): 2 people, 50.00%
  3. Quit Smoking: 2 people, 50.00%
  4. Oedema (fluid collection in tissue): 2 people, 50.00%
  5. Musculoskeletal Pain (pain affects the bones, muscles, ligaments, tendons, and nerves): 2 people, 50.00%
  6. Muscle Spasms (muscle contraction): 2 people, 50.00%
  7. High Blood Pressure: 2 people, 50.00%
  8. High Blood Cholesterol: 2 people, 50.00%
  9. Headache (pain in head): 2 people, 50.00%
  10. Gingivitis (inflammation of gums): 2 people, 50.00%

Other drugs people take *:

  1. Lisinopril: 3 people, 75.00%
  2. Zocor: 2 people, 50.00%
  3. Magnesium Sulfate: 2 people, 50.00%
  4. Amicar: 2 people, 50.00%
  5. Asa: 2 people, 50.00%
  6. Aspirin: 2 people, 50.00%
  7. Cefuroxime: 2 people, 50.00%
  8. Dulera: 2 people, 50.00%
  9. Fluvoxamine Maleate: 2 people, 50.00%
  10. Heparin: 2 people, 50.00%

Other side effects people have besides Bleeding disorders *:

  1. Respiratory Acidosis (respiratory failure or ventilatory failure, causes the ph of blood and other bodily fluids to decrease): 2 people, 50.00%
  2. Pneumonia: 2 people, 50.00%
  3. Haemoglobin Decreased: 2 people, 50.00%
  4. Haematoma (collection of blood outside the blood vessels): 2 people, 50.00%
  5. Coronary Heart Disease (narrowing or blockage of the coronary arteries): 2 people, 50.00%
  6. International Normalised Ratio Increased: 1 person, 25.00%

* Approximation only. Some reports may have incomplete information.

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

How the study uses the data?

The study uses data from the FDA. It is based on poison ivy. All drugs that have the same active ingredients (e.g. brand name and generic drugs) are considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2023 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.